Revolution Medicines, Inc.RVMDNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank86
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P86
Within normal range
Average
-746.65%
Historical baseline
PeriodValueYoY Change
20250.00%-
20240.00%+100.0%
2023-4126.74%-487.3%
2022-702.72%-14.9%
2021-611.59%-157.9%
2020-237.10%-144.2%
2019-97.10%+50.9%
2018-197.91%-